Correlation Between Zoetis and Orchestra BioMed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zoetis and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zoetis and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zoetis Inc and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Zoetis and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zoetis with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zoetis and Orchestra BioMed.

Diversification Opportunities for Zoetis and Orchestra BioMed

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Zoetis and Orchestra is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Zoetis Inc and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Zoetis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zoetis Inc are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Zoetis i.e., Zoetis and Orchestra BioMed go up and down completely randomly.

Pair Corralation between Zoetis and Orchestra BioMed

Considering the 90-day investment horizon Zoetis is expected to generate 37.06 times less return on investment than Orchestra BioMed. But when comparing it to its historical volatility, Zoetis Inc is 3.85 times less risky than Orchestra BioMed. It trades about 0.0 of its potential returns per unit of risk. Orchestra BioMed Holdings is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  751.00  in Orchestra BioMed Holdings on September 2, 2024 and sell it today you would lose (188.00) from holding Orchestra BioMed Holdings or give up 25.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Zoetis Inc  vs.  Orchestra BioMed Holdings

 Performance 
       Timeline  
Zoetis Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zoetis Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Zoetis is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Orchestra BioMed Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orchestra BioMed Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Orchestra BioMed is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Zoetis and Orchestra BioMed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zoetis and Orchestra BioMed

The main advantage of trading using opposite Zoetis and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zoetis position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.
The idea behind Zoetis Inc and Orchestra BioMed Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.